REPRODUCTIVE AND CHILD HEALTH, national scheme, RCH, Maternal health, neonate, maternal and child health, Family planning program, Child survival & safe motherhood program, Components of RCH , Adolescent health care and family life education,
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease.
The National AIDS Control Programme (NACP), launched in 1992, is being implemented as a comprehensive programme for prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV.
NATIONAL AIDS CONTROL PROGRAM
1992- - NACP 1 launched to show down the spread of HIV infection
- national AIDS control board constituted
- NACO setup
1999- - NACP 2 begins focusing on behaviour change , increased decentralization and NGO involvement.
- state AIDS control societies developed .
2002- - national AIDS control policy adopted.
- national blood policy adopted.
2004- - antiretroviral treatment initiated .
2006- - national council on AIDS constituted under chairmanship of prime minister.
- national policy on paediatric ART formulated.
2007- - NACP 3 launched for years (2007-2012)
2012- - NACP 4 launched for next 5 years
Monitoring and Evaluation Framework for MAA: Mothers’ Absolute AffectionNandlal Mishra
Mothers’ Absolute Affection (MAA): A Nationwide programme of the Ministry of Health and Family Welfare, Government of India initiated in August 2016 aims to revitalize efforts towards promotion, protection and support of breastfeeding practices through health systems to achieve higher breastfeeding rate.
REPRODUCTIVE AND CHILD HEALTH, national scheme, RCH, Maternal health, neonate, maternal and child health, Family planning program, Child survival & safe motherhood program, Components of RCH , Adolescent health care and family life education,
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease.
The National AIDS Control Programme (NACP), launched in 1992, is being implemented as a comprehensive programme for prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV.
NATIONAL AIDS CONTROL PROGRAM
1992- - NACP 1 launched to show down the spread of HIV infection
- national AIDS control board constituted
- NACO setup
1999- - NACP 2 begins focusing on behaviour change , increased decentralization and NGO involvement.
- state AIDS control societies developed .
2002- - national AIDS control policy adopted.
- national blood policy adopted.
2004- - antiretroviral treatment initiated .
2006- - national council on AIDS constituted under chairmanship of prime minister.
- national policy on paediatric ART formulated.
2007- - NACP 3 launched for years (2007-2012)
2012- - NACP 4 launched for next 5 years
Monitoring and Evaluation Framework for MAA: Mothers’ Absolute AffectionNandlal Mishra
Mothers’ Absolute Affection (MAA): A Nationwide programme of the Ministry of Health and Family Welfare, Government of India initiated in August 2016 aims to revitalize efforts towards promotion, protection and support of breastfeeding practices through health systems to achieve higher breastfeeding rate.
The slides contain a brief review of NACP 1 through 4.
Key achievements and challenges of NACP Phase 4 have been mentioned. Further, Key strategies of national strategic plan for elimination of HIV/AIDS 2017-2024 has been discussed.
Universal Immunization Program is a vaccination program launched by the Government of India in 1985.
It became a part of Child Survival and Safe Motherhood Program in 1992 and is currently one of the key areas under National Rural Health Mission(NRHM) since 2005.
Program consists of vaccination for 12 diseases -
Tuberculosis
Diphtheria
Pertussis
Tetanus,
Poliomyelitis,
Measles,
Hepatitis B,
Diarrhea,
Japanese-Encephalitis,
Rubella,
Pneumonia
Pneumococcal diseases
Integrated Disease Surveillance Project (IDSP) was launched by Hon’ble Union Minister of Health & Family Welfare in November 2004 for a period upto March 2010. The project was restructured and extended up to March 2012. The project continues in the 12th Plan with domestic budget as Integrated Disease Surveillance Programme under NHM for all States with Budgetary allocation of 640 Cr.
A Central Surveillance Unit (CSU) at Delhi, State Surveillance Units (SSU) at all State/UT head quarters and District Surveillance Units (DSU) at all Districts in the country have been established.
Objectives:
To strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs)
Programme Components:
Integration and decentralization of surveillance activities through establishment of surveillance units at Centre, State and District level.
Human Resource Development – Training of State Surveillance Officers, District Surveillance Officers, Rapid Response Team and other Medical and Paramedical staff on principles of disease surveillance.
Use of Information Communication Technology for collection, collation, compilation, analysis and dissemination of data.
Strengthening of public health laboratories.
The slides contain a brief review of NACP 1 through 4.
Key achievements and challenges of NACP Phase 4 have been mentioned. Further, Key strategies of national strategic plan for elimination of HIV/AIDS 2017-2024 has been discussed.
Universal Immunization Program is a vaccination program launched by the Government of India in 1985.
It became a part of Child Survival and Safe Motherhood Program in 1992 and is currently one of the key areas under National Rural Health Mission(NRHM) since 2005.
Program consists of vaccination for 12 diseases -
Tuberculosis
Diphtheria
Pertussis
Tetanus,
Poliomyelitis,
Measles,
Hepatitis B,
Diarrhea,
Japanese-Encephalitis,
Rubella,
Pneumonia
Pneumococcal diseases
Integrated Disease Surveillance Project (IDSP) was launched by Hon’ble Union Minister of Health & Family Welfare in November 2004 for a period upto March 2010. The project was restructured and extended up to March 2012. The project continues in the 12th Plan with domestic budget as Integrated Disease Surveillance Programme under NHM for all States with Budgetary allocation of 640 Cr.
A Central Surveillance Unit (CSU) at Delhi, State Surveillance Units (SSU) at all State/UT head quarters and District Surveillance Units (DSU) at all Districts in the country have been established.
Objectives:
To strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs)
Programme Components:
Integration and decentralization of surveillance activities through establishment of surveillance units at Centre, State and District level.
Human Resource Development – Training of State Surveillance Officers, District Surveillance Officers, Rapid Response Team and other Medical and Paramedical staff on principles of disease surveillance.
Use of Information Communication Technology for collection, collation, compilation, analysis and dissemination of data.
Strengthening of public health laboratories.
The mission of the Sexually Transmitted Diseases (STD) Control Program is to reduce the occurrence of STDs through disease surveillance, case and outbreak investigation, screening, preventive therapy, outreach, diagnosis, case management, and education.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
1. NACP III&IV
Dr Anupkumar T N
Junior Resident
Dept of Community Medicine
Govt Medical College,Thrissur
2. To cover…
• Brief history
• NACP1,2 achievements
• NACP III- formulation, key strategies,
achievements
• NACP IV-origin, goals,objectives,where are we
now
3. • AIDS was first clinically observed in 1981 in
the United States
4. TIMELINE
1986 - First case of HIV detected
- AIDS Task Force set up by the ICMR
- National AIDS Committee (NAC)established under
MOH
1990 - Medium Term Plan in four states and the four metros
1992 - NACP I to slow down the spread of HIV infection
- National AIDS Control Board constituted
- National AIDS Control Organisation set-up
5. • 1999 - NACP II begins, focusing on behaviour change
- State AIDS Control Societies established
• 2002 - National AIDS Control Policy adopted
- National Blood Policy adopted
• 2004 - ART Treatment initiated
• 2006 - National Council on AIDS
- National Policy on Paediatric ART formulated
6. Key achievements under NACP-I
• National AIDS response structures formed
• Partnership with the World Health
Organisation (WHO)
• Established NACO and the State AIDS Control
Cells
• India's management capacity to respond to
the epidemic.
7. • Improved blood safety,public awareness of
HIV.
• Expanded sentinel surveillance(55 TO 180)
• Expanded STI control and services.
• Improved condom promotion activities.
• Created and disseminated a national HIV
testing policy
8. Key achievements under NACP-II
• NGOs implemented 1,033 targeted
interventions and set up 875
• voluntary counselling and testing (VCT)
centres and 679 STI clinics at the district level.
• Behaviour Sentinel Surveillance (BSS) surveys
were conducted.
• Prevention of parent-to-child transmission
(PPTCT) programme was expanded.
9. • computerized management information
system (CMIS)
• computerized project financial management
system (CPFMS).
• HIV prevention ,care and support
organizations and networks were
strengthened.
• Support from bilateral, multilateral, and other
partner agencies
10.
11. WHY NACP III…?
• The nature of HIV epidemic
• Trained staff and programme manager
• Attention to high risk groups as well as others
• Capacity development with technical support
• Social marketing
12. • Participation from different levels
• Convergence with NRHM
• Underreporting
• Financial investment and policy making
13. Then….
• Consultations with working groups,e-
forums,ngo’s,PLHA networks
• Inputs from studies and assessments
• Consolidate gains and address gaps
• So after one year……………………….
14. NACP III (2007-2012)
• Focus on halt/reverse of epidemic
• Bettering the target of HIV related MDG
• Four pronged approach
15. GUIDING PRINCIPLES
• Three ones
• Equity in prevention
• Rights of PLHA
• Social ownership ,community involvement
• Environmental change for affected
• Universal access
• Human resource
• interventions
16. 4 PRONGED STRATERGY
• Preventing new infection-TI, Scaled up
intervention
• Extend care, support and treatment
• Strengthening the infrastructure for
prevention and care
• Strengthen SIMS
• Budget-11585 crores
19. UPSCALING PREVENTION
• Mainstay of NACP III
• To reduce the spread from HRG to general
population
• Behaviour change stratergy based on effective
IEC campaign
• Continuum of care at all levels
• Interlinked services with apt information
20. In high risk groups
• Increase demand of products& services
• Provide counselling,risk reduction training
• Focus on partner referral
• Demand,access and availability of condoms
• Environement for safe behaviour
• Increase programme sustainability
• Integrate prevention to care, support,
treatment
21. By all these…
• Saturate 80% of HRG and decrease spread
• Special focus to IDU & MSM
22. In bridge population
• Peer led interventions
• Promote,provide condoms
• Develop linkage between different groups
• Peer support groups and safe spaces creation
23. In general population
• Women especially wives of HRG& bridge
groups
• Youth
• Marginalized
• Tribals
24. All these will..
• Set up cadre of link workers
• More access to HIV testing
• Red ribbon clubs for youth
• PPTCT access and treatment improvement
• Assured blood and products
• STI treatment in public and private
• Reduce stigma,discrimination
28. Managing STIs
• 4-6% of adult population,more females
• Expand STI services with NRHM
• Also NGOs,private
• Screen high risk for STI –A KEY STRATERGY
29. CONDOM PROMOTION
• Awareness increased but less use
• Promoting use,ensure availability
• Negotiating skills in HRG
30. BLOOD SAFETY
• Provide safe blood within an hour
• Well coordinated network to reduce HIV
transmission
• 0.5% from1.92%
• Voluntary blood donation to 90%
32. COMPREHENSIVE STRATERGY
• Psychosocial support
• Ensure accessible affordable and sustainable
treatment sevices
• Reduce stigma,poverty and discrimination
• CD4 testing facilities
• Capacity building of ART centres
• Procure ART drugs
36. • Increasing quality of drugs
• Necessary training to all
• Linkage to community care centres
• Adherence to monitoring systems and
treatment
• Ext quality assurance
• Smart health card to patients
37.
38. Care and support
• Improve quality of life,social integration and
dignity
• Partnership with not for profit org.
• Expanding access to services
• Social support,counselling and referrals
through 350 community care centres
41. • Decentralization upto district level
• Strengthening CPFMS&SIMS
• Technical support units at state level
42. Augmenting capacity
• All levels
• All persons involved
• Initiating private sector involvement
• Streamline public health delivery
system,function and accountability
• 380000 persons will get trained
43.
44. Strengthening SIM
• Propose change in purpose and effectiveness
of data collection at all levels
• To maximize effectiveness of available
information
• To implement evidence based planning
• Address stratergic planning,monitoring
,evaluation &surveillance
45. • All programme officers trained
• 1119 sent.sites,127 ART centres,2211 bld
banks,4132 ICTC,866 STI clinics&1220 NGO&TI
interventions in May 2007
46.
47. Decentralization
• From state level to district
• District AIDS Prevention&Control Unit(DAPCU)
• Operate within District societies
• NRHM
• Under DMO
• Non health activities through Distrrict
collector
48. MAINSTREAMING
• Beyond the risks and impact
• Involve more sectors and organisations
• Develop ownership in AIDS prevention and
control programmes
• Lead by national council support by NACO
• 31 member ministries 11 priority departments
for mainstreaming
49. • Can use their medical infrastructure
• Mainstreamed to their workplan
• Allocate their internal resources
56. Epidemic scenario..
• HIV as an epidemic tends to decline
• Both incidence and prevalance decreased
• Prevalance 0.41%-2001,0.35%-2006,0.27%-
2011
• Overall 57% reduction in new HIV
cases2.74lakhs-2000 to 1.16 lakhs-2011
• In FSW-5.06% to2.67%,MSM- 7.41%to4.43%
57. • 29% reduction in estimated annual IADS
related death
• Free ART saved 1.5 lakhs livestill 2011
58. Concerns and challenges
• Need to consolidate successes gained
• Saturating coverage to quality of services
• Address migration which causes emergence of
epidemics
• Treatment demands should be met without
sacrificing prevention
• Regions with diff maturity levels to be
considered
59. • Financial problems to be addressed
• Integration with large health systems
• Social protection schemes for affected
• Stigma and discrimination still remaining
• Innovation in key strategies
60. NACP-IV preparatory phase
• Elaborate and extensive process
• 15 working groups,30 subgroups covering the
whole area
• 624 representatives including community
• Regional,statelevel and e-consultaions
• Overseen by planning commission steering
committee.
61. • All working group met twice in 2011
• Detailed discussions on NACP3 current
status,gaps,priorities,strategic options etc…..
• Reports by working groups
62. NACP-IV
• Goal:accelerate reversal and integrate
response
• 2012-2017
• Reduce new infections by 50%-2007 baseline
• Provide comprehensive care and support to
PLHA and to all those require
63. KEY STRATEGIES
• Intensify and consolidate prevention services
with focus on HRG and vulnerable
• Increase access and promote comprehensive
care and support
• Expand IEC for HRG and general pop focusing
behavior change and demand generation
65. GUIDING PRINCIPLES
• Continue emphasis on agreed action
framework,coordinating authority,M&E system
• Equity
• Gender
• Rights of PLHA
• Civil society representation,participation
• PPP
• Evidence based result oriented programme
implementation
66. Cross cutting areas of focus
• Quality
• Innovation
• Integration
• Leveraging partnerships
• Stigma and discrimination
67. Key priorities
• Prevent new infections
• Prevent antenatal transmission
• Focus on IEC strategies
• Provide treatment for all PLHA
• Reducing stigna and discrimination,GIPA
• Decentralizing
• Ensure effective use of strategic information in all
levels
• Capacity building of NGO& civil society partners
68. • Integrate HIV services to health system
• Mainstreaming departments
71. 1.Preventive
• Targetted interventions
• NSEP&OST for IDU
• Intervention for migrants
• Link worker scheme
• Prevention and control of STI
• Blood safety
• Counselling and testing services
72. • PPTCT
• Condom promotion
• IEC &BCC
• Social mobilization,youth and adolescent
edubcation
• Mainstreaming HIV/AIDS response
• Work place intervention
73. 2.Care ,support and treatment
services
• Lab service for CD4 tesing and other services
• Free ART 1st and 2nd line
• Paediatric ART
• Early infant diagnosis of HIV exposed infants
and below 18 months
• HIV-TB coordination
• Treating opportunistic infection
• Drop in centres for PLHIV networks
74. New initiatives
• Differential strategies for districts based on
data with due weightage to vulnerabilities
• Scale up programmes to target key
vulnerabilitieseg:IDU,migrants,Transgenders
• Scale up multidrug regimen for PPTCT
• Social protection schemes by earmarking
funds
75. • Establishment of metro blood banks and
plasma fractionation centre
• Launch 3rd line ART
• Demand promotion strategies eg:folk,red
ribbon express
77. 1.Intensify and consolidate prevention
services
• Prevention-core strategy
• To cover 90% HRG through TI
• More ICTC in high prevalent areas
• Chc and Phc involvement
• Condom promotion
• Blood bank services
78. • Quality prevention services to HRG
• StrengthenNSEP& OST for IDU
• Reaching to MSM,TG
• Address issues in cover ing and managing rural
intervention
• Provide quality STI/RTI services
• Strengthen positive prevention
80. 2.Comprehensive care,support and
treatment
• Scale up ART centres,linked ARTs,& COE
• Follow up strengthening,improve quality of
counselling
• Use PLHIV linkages
• Guidelines for training staff
81. 3.Expanding IEC
• Increase awareness in general population
• BCC in HRG &vulnerable group
• Focus on demand generation services
• Reaching vulnerable group in rural
82. 4.Building capacities
• Nation state and district level planning
mangement
• Local priorities,need,community involvement
83. Strategic information management
system
• Integrated bioogical &behavioural
surveillance
• National data analysis plan
• National research plan
• SIMS to advance analytic&geographic
information system
• Institutionalising data quality monitoring
system for routine data collection& decision
making
87. Where we are…?
• Among ANC prevalance kerala-0.05 india-0.29
nagaland
• Among FSW prevalance kerala-0.73 india-2.67
andhra,maharashtra
• Among MSM prevalance kerala-0.36
india-4.43 nagaland,chathisgarh
• Among IDU prevalance kerala-4.95 india-7.14
punjab,delhi
88. References
• National AIDS Control Programme Phase III:
2006-2011. Strategy and implementation
plan’. NACO, Ministry of Health and Family
Welfare, Government of India. November 30
• ‘National AIDS Control Programme Phase IV:
2012-2017. Strategy and implementation
plan’. NACO, Ministry of Health and Family
Welfare, Government of India.
89. • HIV IBBS REPORT 2014-15
• Park textbook of preventive and social
medicine